A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma
Clinical trial NCT06554561 · RECRUITING
Trial details
- NCT number
- NCT06554561
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-31
- Primary completion
- 2026-08-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.